Trial Profile
Gosogliptin in patients with type-2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2011
Price :
$35
*
At a glance
- Drugs Gosogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Pfizer
- 01 Feb 2011 Results published in Diabetes Research and Clinical Practice.
- 05 Nov 2010 New trial record.